InMed Pharmaceuticals, Inc. (INM)
1.73
+0.12
(+7.45%)
USD |
NASDAQ |
May 21, 16:00
1.77
+0.04
(+2.31%)
Pre-Market: 08:23
InMed Pharmaceuticals Total Liabilities (Quarterly) : 2.242M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | 36.85M |
| Lexaria Bioscience Corp. | 0.277M |
| Target Group, Inc. (Canada) | 14.62M |
| Tilray Brands, Inc. | 549.12M |
| NervGen Pharma Corp. | 10.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.134M |
| Shareholders Equity (Quarterly) | 6.892M |
| Debt to Equity Ratio | 0.061 |
| Current Ratio | 3.115 |
| Net Debt Paydown Yield | 4.95% |